FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3092814472> ?p ?o ?g. }

• W3092814472 abstract "Abstract Background Device-associated health care-associated infections (DA-HAIs) in intensive care unit (ICU) patients constitute a major therapeutic issue complicating the regular hospitalisation process and having influence on patients’ condition, length of hospitalisation, mortality and therapy cost. Methods The study involved all patients treated > 48 h at ICU of the Medical University Teaching Hospital (Poland) from 1.01.2015 to 31.12.2017. The study showed the surveillance and prevention of DA-HAIs on International Nosocomial Infection Control Consortium (INICC) Surveillance Online System (ISOS) 3 online platform according to methodology of the INICC multidimensional approach (IMA). Results During study period 252 HAIs were found in 1353 (549F/804M) patients and 14,700 patient-days of hospitalisation. The crude infections rate and incidence density of DA-HAIs was 18.69% and 17.49 ± 2.56 /1000 patient-days. Incidence density of ventilator-associated pneumonia (VAP), central line-associated bloodstream infection (CLA-BSI) and catheter-associated urinary tract infection (CA-UTI) per 1000 device-days were 12.63 ± 1.49, 1.83 ± 0.65 and 6.5 ± 1.2, respectively. VAP(137) constituted 54.4% of HAIs, whereas CA-UTI(91) 36%, CLA-BSI(24) 9.6%.The most common pathogens in VAP and CA-UTI was multidrug-resistant (MDR) Acinetobacter baumannii (57 and 31%), and methicillin-resistant Staphylococcus epidermidis (MRSE ) in CLA-BSI (45%). MDR Gram negative bacteria (GNB) 159 were responsible for 63.09% of HAIs. The length of hospitalisation of patients with a single DA-HAI at ICU was 21(14–33) days, while without infections it was 6.0 (3–11) days; p = 0.0001. The mortality rates in the hospital-acquired infection group and no infection group were 26.1% vs 26.9%; p = 0.838; OR 0.9633;95% CI (0.6733–1.3782). Extra cost of therapy caused by one ICU acquired HAI was US$ 11,475/Euro 10,035. Hand hygiene standards compliance rate was 64.7%, while VAP, CLA-BSI bundles compliance ranges were 96.2–76.8 and 29–100, respectively. Conclusions DA-HAIs was diagnosed at nearly 1/5 of patients. They were more frequent than in European Centre Disease Control report (except for CLA-BSI), more frequent than the USA CDC report, yet less frequent than in limited-resource countries (except for CA-UTI). They prolonged the hospitalisation period at ICU and generated substantial additional costs of treatment with no influence on mortality. The Acinetobacter baumannii MDR infections were the most problematic therapeutic issue. DA-HAIs preventive methods compliance rate needs improvement." @default.
• W3092814472 created "2020-10-22" @default.
• W3092814472 creator A5020388893 @default.
• W3092814472 creator A5040469503 @default.
• W3092814472 creator A5048321598 @default.
• W3092814472 creator A5055795254 @default.
• W3092814472 creator A5068178034 @default.
• W3092814472 creator A5083338687 @default.
• W3092814472 date "2020-10-16" @default.
• W3092814472 modified "2023-10-06" @default.
• W3092814472 title "Device associated –health care associated infections monitoring, prevention and cost assessment at intensive care unit of University Hospital in Poland (2015–2017)" @default.
• W3092814472 cites W113206664 @default.
• W3092814472 cites W1909098663 @default.
• W3092814472 cites W1996281568 @default.
• W3092814472 cites W2001280008 @default.
• W3092814472 cites W2029989334 @default.
• W3092814472 cites W2041179379 @default.
• W3092814472 cites W2087865186 @default.
• W3092814472 cites W2091236538 @default.
• W3092814472 cites W2098785083 @default.
• W3092814472 cites W2104012485 @default.
• W3092814472 cites W2109141501 @default.
• W3092814472 cites W2129287036 @default.
• W3092814472 cites W2133918285 @default.
• W3092814472 cites W2137422465 @default.
• W3092814472 cites W2141964898 @default.
• W3092814472 cites W2148149417 @default.
• W3092814472 cites W2150075911 @default.
• W3092814472 cites W2155800098 @default.
• W3092814472 cites W2156990746 @default.
• W3092814472 cites W2160799782 @default.
• W3092814472 cites W2165158988 @default.
• W3092814472 cites W2228968251 @default.
• W3092814472 cites W2273180267 @default.
• W3092814472 cites W2294187522 @default.
• W3092814472 cites W2305550777 @default.
• W3092814472 cites W2409465054 @default.
• W3092814472 cites W2536693079 @default.
• W3092814472 cites W2569901457 @default.
• W3092814472 cites W2782615663 @default.
• W3092814472 cites W2794254540 @default.
• W3092814472 cites W2800042268 @default.
• W3092814472 cites W2801221792 @default.
• W3092814472 cites W2817614309 @default.
• W3092814472 cites W2935965351 @default.
• W3092814472 cites W2977636779 @default.
• W3092814472 cites W3012868903 @default.
• W3092814472 cites W4230357700 @default.
• W3092814472 cites W4236679102 @default.
• W3092814472 cites W4249764287 @default.
• W3092814472 cites W4294990605 @default.
• W3092814472 cites W57351393 @default.
• W3092814472 cites W2982395064 @default.
• W3092814472 doi "https://doi.org/10.1186/s12879-020-05482-w" @default.
• W3092814472 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7562760" @default.
• W3092814472 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33066740" @default.
• W3092814472 hasPublicationYear "2020" @default.
• W3092814472 type Work @default.
• W3092814472 sameAs 3092814472 @default.
• W3092814472 citedByCount "17" @default.
• W3092814472 countsByYear W30928144722021 @default.
• W3092814472 countsByYear W30928144722022 @default.
• W3092814472 countsByYear W30928144722023 @default.
• W3092814472 crossrefType "journal-article" @default.
• W3092814472 hasAuthorship W3092814472A5020388893 @default.
• W3092814472 hasAuthorship W3092814472A5040469503 @default.
• W3092814472 hasAuthorship W3092814472A5048321598 @default.
• W3092814472 hasAuthorship W3092814472A5055795254 @default.
• W3092814472 hasAuthorship W3092814472A5068178034 @default.
• W3092814472 hasAuthorship W3092814472A5083338687 @default.
• W3092814472 hasBestOaLocation W30928144721 @default.
• W3092814472 hasConcept C120665830 @default.
• W3092814472 hasConcept C121332964 @default.
• W3092814472 hasConcept C126322002 @default.
• W3092814472 hasConcept C166888038 @default.
• W3092814472 hasConcept C177713679 @default.
• W3092814472 hasConcept C187212893 @default.
• W3092814472 hasConcept C190139176 @default.
• W3092814472 hasConcept C194828623 @default.
• W3092814472 hasConcept C203014093 @default.
• W3092814472 hasConcept C2776315533 @default.
• W3092814472 hasConcept C2776376669 @default.
• W3092814472 hasConcept C2777184939 @default.
• W3092814472 hasConcept C2777637488 @default.
• W3092814472 hasConcept C2777914695 @default.
• W3092814472 hasConcept C2778523567 @default.
• W3092814472 hasConcept C3018946976 @default.
• W3092814472 hasConcept C501593827 @default.
• W3092814472 hasConcept C523546767 @default.
• W3092814472 hasConcept C54355233 @default.
• W3092814472 hasConcept C61511704 @default.
• W3092814472 hasConcept C71924100 @default.
• W3092814472 hasConcept C86803240 @default.
• W3092814472 hasConcept C89423630 @default.
• W3092814472 hasConceptScore W3092814472C120665830 @default.
• W3092814472 hasConceptScore W3092814472C121332964 @default.
• W3092814472 hasConceptScore W3092814472C126322002 @default.
• W3092814472 hasConceptScore W3092814472C166888038 @default.
• W3092814472 hasConceptScore W3092814472C177713679 @default.
• W3092814472 hasConceptScore W3092814472C187212893 @default.

• next